1-3 of 3
Meredith Regan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Role of Mammalian Target of Rapamycin Inhibitors in the Treatment of Advanced Renal Cancer

Daniel Cho, Sabina Signoretti, Meredith Regan, James W. Mier, Michael B. Atkins
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (2): 758s–763s.
DOI: https://doi.org/10.1158/1078-0432.CCR-06-1986
Published: 25 January 2007
View article
PDF
Journal Articles

Carbonic Anhydrase IX Expression Predicts Outcome of Interleukin 2 Therapy for Renal Cancer

Michael Atkins, Meredith Regan, David McDermott, James Mier, Eric Stanbridge, Amanda Youmans, Philip Febbo, Melissa Upton, Mirna Lechpammer, Sabina Signoretti
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (10): 3714–3721.
DOI: https://doi.org/10.1158/1078-0432.CCR-04-2019
Published: 16 May 2005
View article
PDF
Journal Articles

Update on the Role of Interleukin 2 and Other Cytokines in the Treatment of Patients with Stage IV Renal Carcinoma

Michael B. Atkins, Meredith Regan, David McDermott
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (18): 6342S–6346S.
DOI: https://doi.org/10.1158/1078-0432.CCR-040029
Published: 24 September 2004
View article